Danazol

5 trials 1 recruiting GUrology & Gynaecology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

4 Sponsors

16 Countries

Phase III

Phase II/III

Phase II

Phase III: 3 Phase II/III: 1 Phase II: 1

Indications tested

Primary myelofibrosis 2 Myelofibrosis 1

Sponsors using this IMP

Novartis Pharma AG 2 Celgene Corp. 1 Kartos Therapeutics Inc. 1 Sobi Inc. 1

All trials

5 total

A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending

2024-518231-11-00 Phase II 9 countries Novartis Pharma AG
A study of efficacy and safety of ianalumab in previously treated patients with warm autoimmune haemolytic anaemia Recruiting

2024-510635-21-00 Phase III 6 countries Novartis Pharma AG
PACIFICA: A Phase 3 Study of Pacritinib in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thro… Ended

2024-515953-52-00 Phase III 8 countries Sobi Inc.
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treat… Ended

2024-513912-89-00 Phase II/III 13 countries Kartos Therapeutics Inc.
A study comparing current standard therapies with fedratinib for the treatment of myelofibrosis (either diagnosed alone or after polycythemi… Ended

2024-511972-33-00 Phase III 10 countries Celgene Corp.

Showing 1–5 of 5 trials

← All drugs A–Z